Sort by

Send to

Choose Destination

Links from PubMed

Items: 10


SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study.

Goldstein J, Brouwers H, Romero J, McNamara K, Schwab K, Greenberg S, Rosand J.

J Vasc Interv Neurol. 2012 Aug;5(supp):20-5.


Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids.

Shibeko AM, Woodle SA, Lee TK, Ovanesov MV.

Blood. 2012 Jul 26;120(4):891-9. doi: 10.1182/blood-2011-11-393371.


Poly-N-acetylglucosamine fibers amplify the effectiveness of recombinant factor VIIA on clot formation in hemophilia B canine blood.

Fischer TH, Nichols TC, Scull CM, Smith CJ, Demcheva M.

J Trauma. 2011 Aug;71(2 Suppl 1):S171-5. doi: 10.1097/TA.0b013e31822556f4.


Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.

Gray LD, Hussey MA, Larson BM, Machlus KR, Campbell RA, Koch G, Ezban M, Hedner U, Wolberg AS.

Thromb Res. 2011 Dec;128(6):570-6. doi: 10.1016/j.thromres.2011.04.009.


The interaction of factor VIIa with rehydrated, lyophilized platelets.

Fischer TH, Wolberg AS, Bode AP, Nichols TC.

Platelets. 2008 May;19(3):182-91. doi: 10.1080/09537100701493794.


Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.

Rizoli SB, Boffard KD, Riou B, Warren B, Iau P, Kluger Y, Rossaint R, Tillinger M; NovoSeven Trauma Study Group..

Crit Care. 2006;10(6):R178.


Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.

Brody DL, Aiyagari V, Shackleford AM, Diringer MN.

Neurocrit Care. 2005;2(3):263-7.


Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery?

Kolban M, Balachowska-Kosciolek I, Chmielnicki M.

Eur Spine J. 2006 Jun;15(6):944-52.

Items per page

Supplemental Content

Support Center